all12306-sup-0001-DataS1.docxWord document29KData S1. Methods and results.
all12306-sup-0002-FigS1.tifimage/tif1749KFigure S1. Aggregation behaviour analysis of Mal d 1, Cor a 1 and their mutants via HPSEC (big graphs) and DLS (small graphs).
all12306-sup-0003-FigS2.tifimage/tif1738KFigure S2. Three characteristic RBL titration curves for each of the Mal d 1 (up) and Cor a 1 (down) protein group.
all12306-sup-0004-FigS3.tifimage/tif1879KFigure S3. Chronology of peptide cluster formation during in vitro endolysosomal degradation.
all12306-sup-0005-FigS4.tifimage/tif2534KFigure S4. ELISPOT analysis of splenocytes from immunized mice expressed as the mean of cytokine-secreting cells per 2 × 105 cells ± SEM.
all12306-sup-0005-FigS5.epsimage/eps1240KFigure S5. IgG1 antibody responses at day 28 analysed by ELISA.
all12306-sup-0006-TableS1.docxWord document12KTable S1. List of primers used for the construction of the Mal d 1 and Cor a 1 structural variants.
all12306-sup-0007-TableS2.docxWord document36KTable S2. Patients' sera used within this study.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.